News Daily News Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD Michael O'Riordan November 05, 2019
News Daily News Women More Likely Than Men to Develop Heart Failure After STEMI L.A. McKeown November 04, 2019
News Daily News Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD Todd Neale October 29, 2019
News Daily News Evolocumab Safe and Effective Out to 5 Years: OSLER-1 Yael L. Maxwell October 22, 2019
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Elderly Women Worse Off Than Men Before and After Acute MI Yael L. Maxwell October 22, 2019
News Daily News Statins Started in Kids With FH Provide Benefits in Adulthood Yael L. Maxwell October 17, 2019
News Daily News Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID Caitlin E. Cox October 16, 2019
News Daily News Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury Todd Neale October 14, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population Todd Neale September 18, 2019
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Conference News ESC 2019 Young MI Patients’ Ischemic Risk Extends at Least Two Decades Caitlin E. Cox September 06, 2019
News Conference News ESC 2019 New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL Michael O'Riordan September 05, 2019
News Conference News ESC 2019 Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART Yael L. Maxwell September 04, 2019
News Conference News ESC 2019 ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date Yael L. Maxwell September 03, 2019
News Conference News ESC 2019 Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4 Michael O'Riordan September 02, 2019
News Conference News ESC 2019 Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS Yael L. Maxwell August 31, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News Ezetimibe With Statin Therapy: Biggest Bang in Higher-Risk ACS Patients Michael O'Riordan August 22, 2019